Clinical Trial Update: Shortened LSD Intervention for Major Depressive Disorder [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes a shortened LSD intervention for major depressive disorder. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LSD (lysergic acid diethylamide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Major Depression Moderate, Major Depression Severe | Phase 1 | Status: NOT_YET_RECRUITING